Louisiana Board of Drug and Device Distributors public meetings in 2022
6 substantive meetings from 2022, with official agendas or minutes and plain-English summaries.
Louisiana Board of Drug and Device Distributors
The Louisiana Board of Drug and Device Distributors will hold a regular meeting to approve previous minutes, review financial statements and budgets for FY2023 and FY2024, discuss suspicious order tracking, and consider licensure matters. The board will also review a legal service contract amendment and committee reports on funds policy and track-and-trace software.
- Approval of September 20, 2022 meeting minutes
- Review of FY2023 budget to date and proposed amendments
- Review of FY2024 proposed budget
- Review of annual financial report for FY2022
- Discussion of suspicious order tracking
Louisiana Board of Drug and Device Distributors
The Board approved budget amendments for fiscal year 2023 and adopted the proposed budget for fiscal year 2024. Members also authorized the creation of a database to track suspicious and excessive order reports and the hiring of a temporary employee for data entry.
- Approved September 20, 2022 meeting minutes (7-0-0)
- Approved FY23 budget amendments for July 1, 2022 through June 30, 2023 (7-0-0)
- Approved and adopted FY24 proposed budget for July 1, 2023 through June 30, 2024 (7-0-0)
- Approved development of a database for tracking excessive/suspicious order reports and hiring a temporary employee for data entry (7-0-0)
Louisiana Board of Drug and Device Distributors
The Louisiana Board of Drug and Device Distributors will meet to approve minutes from June 20, 2022, and review financial statements for May through August 2022, including the close of fiscal year 2022. They will consider a proposed accounting services contract and discuss a workshop on the Regulatory Academy on Law, Licensing & Leadership, as well as track and trace technology. Old business includes a committee report on FDA National Standards for the DSCS Act, a self-evaluation report, and a compliance management update. Licensure matters and board vacancies will also be addressed.
- Review of financial statements for May, June, July, August 2022 and close of fiscal year 2022
- Proposed accounting services contract
- Workshop on Regulatory Academy on Law, Licensing & Leadership
- Track and Trace Technology discussion
- Committee report on FDA National Standards for DSCS Act
The Board approved a one-year accounting services contract and a new policy for Americans with Disabilities Act (ADA) requirements. Members also elected a new Secretary/Treasurer and established committees to review bank policies and tracking software.
- Approved accounting services contract with The Accountant Exec LLC for $65/hour, not to exceed $3,200 (Voice Vote)
- Approved ADA requirements policy and procedures in compliance with Act 103 (Voice Vote)
- Elected Trion Horgan as Secretary/Treasurer (Voice Vote)
- Approved June 20, 2022 meeting minutes (Voice Vote)
- Established committee to review bank account and certificate of deposit policy (Voice Vote)
- Established committee to review serialization scanners and tracking software providers (Voice Vote)
Louisiana Board of Drug and Device Distributors
The Louisiana Board of Drug and Device Distributors will hold its annual meeting to approve routine items including meeting minutes, contract renewals for accounting, inspection, and legal services, and a policy amendment on facility inspection complexity ratings. The board will also discuss financial statements, budget review, annual staff performance reviews, and election of officers.
- Renewal of contracts: Accounting Services (O. Nugent), Inspection Services (D. Andrus), Legal Services (Becknell Law Firm and C. Cangelosi)
- Policy and Procedures amendment: Facility Inspection Complexity Ratings
- Annual election of officers
- Financial statements for February, March, April 2022 and budget review for current fiscal year
- Discussion of FDA National Standards for DSCS Act
The Board approved renewals for accounting, inspection, and legal services, and authorized the use of a new board management platform. Members also approved a 5% merit salary adjustment for Executive Director George Lovecchio and ratified current board officers.
- Approved accounting services contract with Ouida Nugent for $6,000 (July 1, 2022 - June 30, 2024)
- Approved facility inspection services contract with Danny Andrus for $35,000 (July 1, 2022 - June 30, 2023)
- Approved legal services contract with The Becknell Law Firm, APLC for $23,000 (July 1, 2022 - June 30, 2023)
- Approved legal services contract with Celia R. Cangelosi for $10,000 (July 1, 2022 - June 30, 2023)
- Designated George Lovecchio as the Board’s records officer effective July 1, 2022
- Approved 5% merit salary adjustment for Executive Director George Lovecchio
- Ratified current officers to another year of service
- Authorized administrative staff to obtain the OnBoard/Passageways Inc. management platform
Louisiana Board of Drug and Device Distributors
The Louisiana Board of Drug and Device Distributors will hold its annual meeting on June 14, 2022, to approve minutes, review financial statements, and renew service contracts for accounting, inspection, and legal counsel. The board will also consider an amendment to facility inspection complexity ratings, discuss legislative session outcomes, and elect officers. The agenda is largely procedural with no major policy changes or specific dollar amounts disclosed.
- Renewal of accounting services (O. Nugent), inspection services (D. Andrus), and legal services (Becknell Law Firm and C. Cangelosi)
- Amendment to Facility Inspection Complexity Ratings policy
- Annual election of board officers
- Review of 2022 Louisiana Regular Legislative Session
- Discussion of National Standards for DSCS Act (drug supply chain security)
Louisiana Board of Drug and Device Distributors
The Louisiana Board of Drug and Device Distributors will hold a regular meeting on March 8, 2022. Items include approval of minutes, financial statements for November 2021 through January 2022, and the current fiscal year budget. The board will consider renewing contracts for a facility inspector and a compliance manager. Old business includes a discussion on the legality of local authorities filling O2 cylinders and an update on NADDI programs. New business covers the annual EEO policy review, an overview of the 2022 legislative session, and FDA standards for the DSCS Act.
- Approval of minutes from December 7, 2021 meeting
- Financial statements for Nov 2021, Dec 2021, Jan 2022
- Renewal of Facility Inspector and Compliance Manager contracts
- Discussion on legality of local authorities filling O2 cylinders
- Overview of 2022 Louisiana Legislative Regular Session and FDA DSCS Act standards
The Board approved two service contracts for facility inspections and licensure compliance management. It also established a committee to review FDA national standards for the Drug Supply Chain Safety Act and approved its Equal Employment Opportunity Policy.
- Approved contract for John Liggio for facility inspections, not to exceed $20,000 (4-0)
- Approved contract for Victoria Bienvenu for licensure compliance consulting, not to exceed $48,500 (4-0)
- Approved Equal Employment Opportunity Policy as presented (4-0)
- Created National Standards Review committee to submit comments to FDA by June 6, 2022 (4-0)
- Approved meeting minutes from December 7, 2021 (4-0)